Dr. DeClaire and Dr. Frisch have been selected to be part of one of 30 group orthopaedic practices in the US, and the only orthopaedic practice in Michigan, participating in the Zimmer Biomet mymobility® Clinical Study.
Zimmer Biomet is collaborating with Apple in an attempt in an attempt to transform the patient journey for two of the most common surgeries that Americans undergo each year – knee and hip replacement. This collaboration has yielded mymobility, an app that uses Apple Watch® and iPhone® to facilitate a new level of connection between patients and their surgeons, which may improve the often-challenging journey that patients experience, while also delivering continuous data to surgeons so they can optimize care and improve outcomes.
With its simple and intuitive interface, the mymobility patient experience keeps patients informed and educated on next-steps through notifications, video tutorials, to-dos and reminders throughout their journey. For the first time, this study will combine patient reported feedback with continuous biometric and behavioral data from the mymobility with Apple Watch solution, providing new information about the patient journey. Understanding their condition and care plan gives patients the ability to actively participate in optimizing their surgical outcome.
Interested? Contact us to find out if you qualify.
mymobility is a registered trademark of Zimmer Biomet. Apple Watch and iPhone are registered trademarks of Apple, Inc.